Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4

Go back to Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4
(NASDAQ: LEXX) Delayed: 3.07 -0.02 (0.65%)
Previous Close $3.09    52 Week High $ 
Open $3.18    52 Week Low $ 
Day High $3.24    P/E N/A 
Day Low $2.92    EPS $ 
Volume 32,061       

(NASDAQ: LEXXW) Delayed: 0.00 --0 (-0%)
Previous Close $0.00    52 Week High $ 
Open $0.00    52 Week Low $ 
Day High $0.00    P/E N/A 
Day Low $0.00    EPS $ 
Volume 37,350